Phase 3Recruiting

HFrEF Polypill in Sri Lanka RCT

Heart Failure With Reduced Ejection Fraction Polypill in Sri Lanka: A Multi-Center Type I Hybrid Randomized Controlled Trial

Sponsor
Washington University School of Medicine (Academic or other)
Enrolment
1,672 planned
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
Usual Care; HFrEF Polypill
Ages
adults, older adults
Registry
NCT07569640

From the registry

The aim of this study is to evaluate, in adults with HFrEF in Sri Lanka, the effects of an HFrEF polypill implementation strategy on the composite rate of cardiovascular disease mortality and recurrent heart failure hospitalizations, compared with usual care over a minimum of 12-months of follow-up. Primary outcome of the study: 1\) Composite rate of cardiovascular disease mortality and recurrent heart failure hospitalizations over study duration Secondary outcomes of the study: 1. Rate of cardiovascular disease mortality over study duration 2. Rate of recurrent heart failure hospitalizations over the study duration 3. Rate of all-cause mortality over the study duration 4. Change in left ventricular ejection fraction at 12-months and end of study assessed by transthoracic echocardiogram 5. Change in BNP levels at 12 months and end of study 6. Change in overall and domain specific health-related quality of life at 12-months and end of study assessed by a translated validated version of the Kansas City Cardiomyopathy Questionnaire (KCCQ-23) 7. Change in physician-reported New York…

Primary outcomes

  • Composite rate of cardiovascular disease mortality and recurrent heart failure hospitalizations over study duration
Full record on ClinicalTrials.gov